Skip to Main Content

Paper Details

Trans-channel fluorescence learning improves high-content screening for Alzheimer's disease therapeutics.
Nat Mach Intell
5
2022
Author NameAffiliation
Stanley B PrusinerInstitute for Neurodegenerative Diseases, University of California san francisco
Sourav BandyopadhyayUniversity of California san francisco
Sourav BandyopadhyayHelen Diller Family Comprehensive Cancer Center, University of California san francisco
Atul J ButteBakar Computational Health Sciences Institute, University of California san francisco
Atul J ButteUniversity of California san francisco
Atul J ButteCenter for Data-Driven Insights and Innovation, University of California
Michael J KeiserInstitute for Neurodegenerative Diseases, University of California san francisco
Michael J KeiserBakar Computational Health Sciences Institute, University of California san francisco
Michael J KeiserDepartment of Pharmaceutical Chemistry, University of California san francisco
Michael J KeiserUniversity of California san francisco
Michael J KeiserKavli Institute for Fundamental Neuroscience, University of California san francisco
  • 1 - 11

Datasets